NCT06750692 Comparison of the Effects of Mirror Therapy,rTMS and Robotic-assisted Hand Therapy in Stroke Patients
| NCT ID | NCT06750692 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Afyonkarahisar Health Sciences University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2024-12-27 |
| Primary Completion | 2026-04-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2024-12-27 with a primary completion date of 2026-04-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to investigate the comparison of the effects of mirror therapy, Repetitive Transcranial Magnetic Stimulation and robot-assisted hand therapy added to conventional neurological rehabilitation on upper extremity function, quality of life and pain in stroke.
Eligibility Criteria
Inclusion Criteria: * Patients who applied to Afyonkarahisar Health Sciences University Hospital Physical Medicine and Rehabilitation Polyclinic with the diagnosis of hemiplegia after a cerebrovascular accident in the inpatient ward or as an outpatient for neurological rehabilitation after taking the anamnesis and physical examination, who met the inclusion criteria and eliminated the exclusion criteria * Female and male patients between the ages of 40-80 * stroke at least 3 months ago * voluntarily agreed to participate in the study regularly, whose health status is suitable for rehabilitation and who are medically stable * mini mental test score of 15 and above * Neurologically stable patient Exclusion Criteria: * significant comorbidities such as serious heart disease (aortic stenosis, angina, hypertrophic cardiomyopathy, arrhythmia, pacemaker) and uncontrolled hypertension * history of epilepsy, antiepileptic drug use * intracranial metal objects * intraauricular implants * cognitive dysfunction * upper extremity peripheral nerve injuries * malignancy * active infection * skin infections or open wounds in the application area * inflammatory diseases * orthopedic injuries that may limit maximum effort capacity * brain lesion or drug use history that may affect the seizure threshold * increased intracranial pressure * uncontrolled migraine * severe spasticity in the hand (MAS≥3) * contracture in the hand * have had a fracture or surgery on the hemiplegic side in the last 6 months * severe visual impairment * severe depression
Contact & Investigator
Selma Eroglu, MD
PRINCIPAL INVESTIGATOR
Afyonkarahisar Health Sciences University
Frequently Asked Questions
Who can join the NCT06750692 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 80 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06750692 currently recruiting?
Yes, NCT06750692 is actively recruiting participants. Contact the research team at drsanberkbeklen@gmail.com for enrollment information.
Where is the NCT06750692 trial being conducted?
This trial is being conducted at Afyonkarahisar, Turkey (Türkiye).
Who is sponsoring the NCT06750692 clinical trial?
NCT06750692 is sponsored by Afyonkarahisar Health Sciences University. The principal investigator is Selma Eroglu, MD at Afyonkarahisar Health Sciences University. The trial plans to enroll 120 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.